| NAME |
RISANKIZUMAB-RZAA 75MG/0.83ML INJ,SYRINGE,KIT |
| VA GENERIC NAME |
RISANKIZUMAB-RZAA |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Risankizumab-rzaa_(Skyrizi)_(Sep_2022).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| FORMULARY DESIGNATOR TEXT |
|
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
75 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2019-05-09 00:00:00 |
| UNITS |
MG/0.83ML |
| NATIONAL FORMULARY NAME |
RISANKIZUMAB-RZAA INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2019-05-02 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
RISANKIZUMAB-RZAA 75MG/0.83ML SYR KIT |
| VA PRODUCT IDENTIFIER |
R0390 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
SYR |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4038350 |
| EFFECTIVE DATE/TIME |
-
- 2019-05-02 00:00:00
- STATUS: ACTIVE
-
- 2019-05-09 00:00:00
- STATUS: INACTIVE
|
